{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:54Z","timestamp":1791257994913,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The transfer of membrane proteins between cells during contact, known as trogocytosis, can create novel cells with a unique phenotype and altered function. We demonstrate that trogocytosis is more common in multiple myeloma (MM) than chronic lymphocytic leukemia and Waldenstrom macroglobulinaemia; that T cells are more probable to be recipients than B or natural killer cells; that trogocytosis occurs independently of either the T-cell receptor or HLA compatibility; and that after trogocytosis, T cells with acquired antigens can become novel regulators of T-cell proliferation. We screened 168 patients with MM and found that CD86 and human leukocyte antigen G (HLA-G) were antigens commonly acquired by T cells from malignant plasma cells. CD3+CD86acq+ and CD3+ HLA-Gacq+ cells were more prevalent in bone marrow than peripheral blood samples. The presence of either CD86 or HLA-G on malignant plasma cells was associated with a poor prognosis. CD38++ side population cells expressed HLA-G, suggesting that these putative myeloma stem cells could generate immune tolerance. HLA-G+ T cells had a regulatory potency similar to natural Tregs, thus providing another novel mechanism for MM to avoid effective immune surveillance.<\/jats:p>","DOI":"10.1182\/blood-2012-03-416792","type":"journal-article","created":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T21:30:22Z","timestamp":1339968622000},"page":"2055-2063","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":102,"title":["CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis"],"prefix":"10.1182","volume":"120","author":[{"given":"Ross","family":"Brown","sequence":"first","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karieshma","family":"Kabani","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Favaloro","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Joy","family":"Ho","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gibson","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Fromm","sequence":"additional","affiliation":[{"name":"Dendritic Cell Biology and Therapeutics, Australian and New Zealand Army Corps (ANZAC) Research Institute, Sydney, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Suen","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narelle","family":"Woodland","sequence":"additional","affiliation":[{"name":"School of Medical and Molecular Biosciences, University of Technology, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah","family":"Nassif","sequence":"additional","affiliation":[{"name":"School of Medical and Molecular Biosciences, University of Technology, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hart","sequence":"additional","affiliation":[{"name":"Dendritic Cell Biology and Therapeutics, Australian and New Zealand Army Corps (ANZAC) Research Institute, Sydney, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Joshua","sequence":"additional","affiliation":[{"name":"Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2019111818043502400_B1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"Joly","year":"2003","journal-title":"Nat Immunol"},{"issue":"5441","key":"2019111818043502400_B2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.286.5441.952","article-title":"TCR-mediated internalization of peptide-MHC complexes acquired by T cells.","volume":"286","author":"Huang","year":"1999","journal-title":"Science"},{"issue":"6","key":"2019111818043502400_B3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1096\/fj.01-0933rev","article-title":"Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance.","volume":"16","author":"Hudrisier","year":"2002","journal-title":"FASEB J"},{"issue":"1","key":"2019111818043502400_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v26.i1.10","article-title":"MHC transfer from APC to T cells following antigen recognition.","volume":"26","author":"Wetzel","year":"2006","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"2019111818043502400_B5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nri2020","article-title":"Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response.","volume":"7","author":"Davis","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111818043502400_B6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-3083.2007.01996.x","article-title":"Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter with CD8(+) cells.","volume":"66","author":"Riond","year":"2007","journal-title":"Scand J Immunol"},{"issue":"4","key":"2019111818043502400_B7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/cmi.2008.32","article-title":"Intercellular trogocytosis plays an important role in modulation of immune responses.","volume":"5","author":"Ahmed","year":"2008","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2019111818043502400_B8","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells.","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111818043502400_B9","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood-2006-12-062059","article-title":"Fast track to becoming a regulatory T cell: \u201ctrogocytosis\u201d of immune-tolerogenic HLA-G.","volume":"109","author":"Wiendl","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111818043502400_B10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cyto.a.20728","article-title":"Patch bandits.","volume":"75","author":"T\u00e1rnok","year":"2009","journal-title":"Cytometry"},{"issue":"4","key":"2019111818043502400_B11","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4049\/jimmunol.166.4.2505","article-title":"Acquisition of CD80 (B7-1) by T cells.","volume":"166","author":"Sabzevari","year":"2001","journal-title":"J Immunol"},{"issue":"304","key":"2019111818043502400_B12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.vetimm.2003.12.006","article-title":"B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion.","volume":"98","author":"Vahlenkamp","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"2019111818043502400_B13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/0008-5472.CAN-07-3119","article-title":"Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.","volume":"68","author":"Machlenkin","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"2019111818043502400_B14","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.161.11.5943","article-title":"Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.","volume":"161","author":"Behrens","year":"1998","journal-title":"J Immunol"},{"issue":"7","key":"2019111818043502400_B15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.","volume":"203","author":"Liu","year":"2006","journal-title":"Exp Med"},{"issue":"4","key":"2019111818043502400_B16","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4049\/jimmunol.0901570","article-title":"The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell.","volume":"184","author":"Daubeuf","year":"2010","journal-title":"J Immunol"},{"issue":"1-2","key":"2019111818043502400_B17","first-page":"1","article-title":"A CFSE based assay for measuring CD4+ CD25+ regulatory T cell mediated suppression of auto-antogen specific and polyclonal T-cell responses.","volume":"322","author":"Venken","year":"2007","journal-title":"J Immunol"},{"issue":"21","key":"2019111818043502400_B18","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"PNAS"},{"issue":"2","key":"2019111818043502400_B19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0378(99)00034-0","article-title":"HLA-G inhibits the allogeneic proliferative response.","volume":"43","author":"Riteau","year":"1999","journal-title":"J Reprod Immunol"},{"issue":"3","key":"2019111818043502400_B20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/eji.200736918","article-title":"Soluble HLA-G molecules impair natural killer\/dendritic cell crosstalk via inhibition of dendritic cells.","volume":"38","author":"Gros","year":"2008","journal-title":"Eur J Immunol"},{"issue":"12","key":"2019111818043502400_B21","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","article-title":"Cutting edge: soluble HLA-G1 triggers CD95\/CD95 ligand-mediated apoposis in activated CD8 cells by interacting with CD8.","volume":"164","author":"Fournel","year":"2000","journal-title":"J Immunol"},{"issue":"12","key":"2019111818043502400_B22","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood-2007-04-083139","article-title":"CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.","volume":"110","author":"Naji","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2019111818043502400_B23","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2007-12-127662","article-title":"Beyond the increasing complexity of the immunomodulatory HLA-G molecule.","volume":"111","author":"Carosella","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111818043502400_B24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111818043502400_B25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/leu.2008.15","article-title":"NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.","volume":"22","author":"Maki","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2019111818043502400_B26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood-2004-08-3335","article-title":"HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.","volume":"105","author":"N\u00fcckel","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111818043502400_B27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2007.06647.x","article-title":"Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.","volume":"138","author":"Sebti","year":"2007","journal-title":"Brit J Haematol"},{"issue":"7","key":"2019111818043502400_B28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0145-2126(02)00228-X","article-title":"Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.","volume":"27","author":"Pol\u00e1kov\u00e1","year":"2003","journal-title":"Leuk Res"},{"issue":"5","key":"2019111818043502400_B29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1399-0039.1996.tb02682.x","article-title":"HLA-G transcription studies during the different stages of normal and malignant hematopoiesis.","volume":"48","author":"Amiot","year":"1996","journal-title":"Tissue Antigens"},{"issue":"5","key":"2019111818043502400_B30","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood-2003-10-3372","article-title":"Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2.","volume":"103","author":"Urosevic","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111818043502400_B31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1582-4934.2008.00175.x","article-title":"Unfavourable clinical implications for HLA-G expression in acute myeloid leukemia.","volume":"12","author":"Yan","year":"2008","journal-title":"J Cell Mol Med"},{"key":"2019111818043502400_B32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept.","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2019111818043502400_B33","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/10428190802272676","article-title":"Presence of hoechst low side populations in multiple myeloma.","volume":"49","author":"Loh","year":"2008","journal-title":"Leuk Lymph"},{"issue":"16","key":"2019111818043502400_B34","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-04-2672","article-title":"Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.","volume":"11","author":"Tamura","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2019111818043502400_B35","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2002-011262","article-title":"Intense expression of the B7.2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.","volume":"87","author":"Shah","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019111818043502400_B36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood.V96.4.1274","article-title":"B7-2-positive myeloma: incidence, clinical characteristics, prognostic significance, and implications for tumor immunotherapy.","volume":"96","author":"Pope","year":"2000","journal-title":"Blood"},{"issue":"2","key":"2019111818043502400_B37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.23941","article-title":"Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.","volume":"124","author":"Perez-Andres","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"2019111818043502400_B38","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1182\/blood-2006-09-047290","article-title":"Acquisition of antigen presentasome (APS), an MHC\/costimulatory complex, is a checkpoint of memory homeostasis.","volume":"109","author":"Mostb\u00f6ck","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111818043502400_B39","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111818043502400_B40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.thj.6200183","article-title":"A mouse model for immunotherapy of myeloma.","volume":"3","author":"Bogen","year":"2002","journal-title":"Hematol J"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/10\/2055\/1357462\/zh803612002055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/10\/2055\/1357462\/zh803612002055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T12:48:58Z","timestamp":1687524538000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/10\/2055\/30471\/CD86-or-HLAG-can-be-transferred-via-trogocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,6]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,9,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-416792","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,6]]}}}